The epidemiology of pancreatic cancer;A hasnyálmirigyrák epidemiológiája

Orvosi Hetilap

Volumn 151, Issue 44, 2010, Pages 1816-1822

  Lakatos, Gábor ^a   Tulassay, Zsolt ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

hereditary pancreatitis; incidence; mortality; pancreatic cancer

Indexed keywords

BRCA2 PROTEIN;

CANCER MORTALITY; CHRONIC PANCREATITIS; DNA POLYMORPHISM; EARLY DIAGNOSIS; ENVIRONMENTAL FACTOR; GENE MUTATION; HUMAN; INCIDENCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS CANCER; PATHOGENESIS; REVIEW; RISK FACTOR; SMOKING;

AGE FACTORS; FEMALE; FOOD HABITS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; OBESITY; PANCREATIC NEOPLASMS; PANCREATITIS; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; SMOKING; UNITED STATES;

EID: 77958497914     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2010.28986     Document Type: Review

References (49)

1. Lowenfels, A. B., Maisonneuve, P.: Risk factors for pancreatic cancer. J. Cell. Biochem., 2005, 95, 649-656.
2. Shaib, Y. H., Davila, J. A., El-Serag, H. B.: The epidemiology of pancreatic cancer in the United States: changes below the surface. Aliment. Pharmacol. Ther., 2006, 24, 87-94.
3. Curado, M. P., Edwards, B. K., Shin, H. R. és mtsai (eds): Cancer incidence in fi ve continents. Vol. 9 (IARC Scientifi c publications, No 160.), Lyon, 2007.
4. Kinoshita, S., Wagatsuma, Y., Okada, M.: Geographical distribution for malignant neoplasm of the pancreas in relation to selected climatic factors in Japan. Int. J. Health Geogr., 2007, 6, 34.
5. Giavanucci, E., Liu, Y., Rimm, E. B. és mtsai: Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J. Natl. Cancer Inst., 2006, 98, 451-459.
6. Zhou, J., Enewold, L., Stojadinovic, A. és mtsai: Incidence rates of exocrine and endocrine pancreatic cancers in the United States. Cancer Causes Control., 2010, 21, 853-861.
7. Zhang, J., Dhakal, I., Yan, H. és mtsai: Trends in pancreatic cancer incidence in nine SEER cancer registries, 1973-2002. Ann. Oncol., 2007, 18, 1268-1279.
8. Lepage, C., Bouvier, A. M., Phelip, J. M. és mtsai: Incidence and management of malignant digestive endocrine tumours in a well defi ned French population. Gut, 2004, 53, 549-553.
9. Melvin, K. L., Jessica, A. D., Yasser, H. S.: Incidence and survival of pancreatic head and body and tail cancers: a population-based study in the United States. Pancreas, 2010, 39, 458-462.
10. Karpoff, H. M., Klimstra, D. S., Brennan, M. F. és mtsa: Results of total pancreatectomy for adenocarcinoma of the pancreas. Arch. Surg., 2001, 136, 44-47.
11. Sahmoun, A. E., D'Agostino, R. A. Jr., Bell, R. A. és mtsa: International variation in pancreatic cancer mortality for the period 1955-1998. Eur. J. Epidemiol., 2003, 18, 801-816.
12. Govindarajan, A., Tan, J. C., Baxter, N. N. és mtsai: Variations in surgical treatment and outcomes of patients with pancreatic cancer: a population-based study. Ann. Surg. Oncol., 2008, 15, 175-185.
13. Baxter, N. N., Whitson, B. A., Tuttle, T. M.: Trends in the treatment and outcome of pancreatic cancer in the United States. Ann. Surg. Oncol., 2007, 14, 1320-1326.
14. Raimondi, S., Maisonneuve, P., Lowenfels, A. B.: Epidemiology of pancreatic cancer: an overview. Nat. Rev. Gastroenterol. Hepa-tol., 2009, 6, 699-708.
15. Wahl, M. M., Shah, N., Schrock, C. E. és mtsai: Reproductive factors and risk of pancreatic cancer in women: a review of the literature. Ann. Epidemiol., 2009, 19, 103-111.
16. Horner, M. J., Ries, L. A. G., Krapcho, M. és mtsai: SEER Cancer Satistics Review, 1975-2006. National Cancer Institute (online), http://seer.cancer.gov/csr/1975-2006 (2009).
17. Muscat, J. E., Djordjevic, M. V., Colosimo, S. és mtsai: Racial differences in exposure and glucuronidation of the tobacco-spe-cifi c carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-bu-tanone (NNK). Cancer, 2005, 103, 1420-1426.
18. Lichtenstein, P., Holm, N. V., Verkasalo, P. K. és mtsai: Enviro-mental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med., 2000, 343, 78-85.
19. Silverman, D. T., Dunn, J. A., Hoover, R. N. és mtsai: Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J. Natl. Cancer Inst., 1994, 86, 1510-1516.
20. Doll, R., Peto, R., Wheatley, K. és mtsai: Mortality in relation to smoking: 40 years' observations on male British doctors. Br. Med. J., 1994, 309, 901-911.
21. Iodice, S., Gandini, S., Maisonneuve, P. és mtsa: Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langen-becks Arch. Surg., 2008, 393, 535-545.
22. Michaud, D. S., Skinner, H. G., Wu, K. és mtsai: Dietary patterns and pancreatic cancer risk in men and women. J. Natl. Cancer Inst., 2005, 97, 518-524.
23. Larsson, S. C., Hakansson, N., Giovannucci, E. és mtsa: Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men. J. Natl. Cancer Inst., 2006, 98, 407-413.
24. Grant, W. B., Mohr, S. B.: Ecological studies of ultraviolet B, vitamin D and cancer since 2000. Ann. Epidemiol, 2009, 19, 446-454.
25. Michaud, D. S., Giovanucci, E., Willett, W. C. és mtsai: Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts. Cancer Epidemiol. Biomark-ers Prev., 2001, 10, 429-437.
26. Anderson, L. N., Cotterchio, M., Gallinger, S.: Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario, Canada. Cancer Causes Control., 2009, 20, 825-834.
27. Gnagnarella, P., Gandini, S., La Vecchia, C. és mtsa: Glycemic index, glycemic load, and cancer risk: a meta-analysis. Am. J. Clin. Nutr., 2008, 87, 970-977.
28. Renehan, A. G., Tyson, M., Egger, M. és mtsai: Body-mass index and incidence of cancer: a systematic review and meta-analysis of propective observational studies. Lancet, 2008, 371, 569-578.
29. Larsson, S. C., Orsini, N., Wolk, A.: Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies. Int. J. Cancer, 2007, 120, 1993-1998.
30. Li, D., Morris, J. S., Liu, J. és mtsai: Body mass index and risk, age of onset, and survival of patients with pancreatic cancer. JAMA, 2009, 301, 2553-2562.
31. Calle, E. E., Rodriguez, C., Walker-Thurmond, K. és mtsai: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med., 2003, 348, 1625-1638.
32. Lowenfels, A. B., Maisonneuve, P., Whitcomb, D. C. et al., International Pancreatitis Study Group: Pancreatitis and the risk of pancreatic cancer. N. Engl. J. Med., 1993, 328, 1433-1437.
33. Howes, N., Lerch, M. M., Greenhalf, W. és mtsai: Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin. Gastroenterol. Hepatol., 2004, 2, 252-261.
34. Huxley, R., Ansary-Moghaddam, A., Berrington de González, A. és mtsai: Type-II diabetes and pancreatic cancer: a metaanalysis of 36 studies. Br. J. Cancer, 2005, 92, 2076-2083.
35. Li, D., Yeung, S. C., Hassan, M. M. és mtsai: Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology, 2009, 137, 482-488.
36. Maitra, A., Hruban, R. H.: Pancreatic cancer. Ann. Rev. Pathol., 2008, 3, 157-188.
37. Langman, M. J., Cheng, K. K., Gilman, E. A. és mtsa: Effect of anti-infl ammatory drugs on overall risk of common cancer: case-control study in general practice research database. Br. Med. J., 2000, 320, 1642-1646.
38. Gandini, S., Lowenfels, A. B., Jaffee, E. M. és mtsai: Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanisms. Cancer Epidemiol. Biomarkers Prev., 2005, 14, 1908-1916.
39. American Cancer Society: Cancer facts and fi gures 2009, http:// www.cancer.org/acs/groups/content/@nho/documents/ document/500809webpdf.pdf
40. Altekruse, S. F., Kosary, C. L., Krapcho, M. és mtsai (eds): SEER Cancer Statistics Review, 1975-2007, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975-2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010.
41. Vasen, H. F., Gruis, N. A., Frants, R. R. és mtsai: Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specifi c 19 deletion of 16p (p16-Leiden). Int. J. Cancer, 2000, 87, 809-811.
42. Lowenfels, A. B., Maisonneuve, P., DiMagno, E. P. és mtsai: Hereditary pancreatitis and the risk of pancreatic cancer. International hereditary pancreatitis study group. J. Natl. Cancer Inst., 1997, 89, 442-446.
43. Su, G. H., Hruban, R. H., Bansal, R. K. és mtsai: Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am. J. Pathol., 1999, 154, 1835-1840.
44. Pogue-Geile, K. L., Chen, R., Bronner, M. P. és mtsai: Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism. PLoS Med., 2006, 3, e516.
45. Maisonneuve, P., FitzSimmons, S. C., Neglia, J. P. és mtsai: Cancer risk in nontransplanted and transplanted cystic fi brosis patients: a 10-year study. J. Natl. Cancer Inst., 2003, 95, 381-387.
46. Couch, F. J., Johnson, M. R., Rabe, K. G. és mtsai: The prevalence of BRCA2 mutation in familial pancreatic cancer. Cancer Epidemiol. Biomarkers Prev., 2007, 16, 342-346.
47. Efthimiou, E., Crnogorac-Jurcevic, T., Lemoine, N. R. és mtsa: Inherited predisposition to pancreatic cancer. Gut, 2001, 48, 143-147.
48. Kleihues, P., Schauble, B., zur Hausen, A. és mtsai: Tumors associated with p53 germline mutations: a synopsis of 91 families. Am. J. Pathol., 1997, 150, 1-13.
49. Geary, J., Sasieni, P., Houlston, R. és mtsai: Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC). Fam. Cancer, 2008, 7, 163-172.